2-HG |
2-hydroxyglutarate |
5-FU |
5-fluorouracil |
ACC |
acetyl CoA carboxylase |
2-HG |
2-hydroxyglutarate |
ADP |
adenosine diphosphate |
αKG |
α ketoglutarate |
AKT |
protein kinase B |
AML |
acute myeloid leukemia |
AMPK |
5’ AMP-activated protein kinase |
Bax |
Bcl-2-associated X protein |
BW |
body weight |
CAF |
cancer-associated fibroblast |
CD |
cluster of differentiation |
CDK |
cyclin-dependent kinase |
CIMP |
CpG island methylator phenotype |
COX |
cyclooxygenase |
CRC |
colorectal cancer |
CSC |
cancer stem cell |
CYP |
cytochrome P450 |
DCA |
dichloroacetate |
dMMR |
DNA mismatch repair system |
DNA |
deoxyribonucleic acid |
E4BP |
eIF4E binding protein |
ECM |
extracellular matrix |
EGFR |
endothelial growth factor receptor |
EMA |
European Medicines Agency |
EMT |
epithelial–mesenchymal transition |
ERK |
extracellular-signal regulated kinases |
FAD |
flavin adenine dinucleotide |
FDA |
Food and Drug Administration |
FOLFIRI |
fluorouracil, leucovorin and irinotecan |
FOLFIRINOX |
fluorouracil, leucovorin, irinotecan and oxaliplatin |
FOLFOX |
fluorouracil, leucovorin and oxaliplatin |
G6PD |
glucose-6-phosphate dehydrogenase |
GLS |
glutaminase |
GLUD |
glutamate dehydrogenase |
GLUT |
glucose transporter |
GOT |
glutamic-oxaloacetic transaminase |
GTP |
glutamate pyruvate transaminase |
GTP |
guanosine-5’-triphosphate |
HIF |
hypoxia-inducible factor |
HK |
hexokinase |
HRE |
hypoxia response element |
IBD |
inflammatory bowel disease |
IC50 |
inhibitory concentration (50%) |
IDH |
isocitrate dehydrogenase |
IGF |
insulin-like growth factor |
KGDH |
α-ketoglutarate dehydrogenase complex |
LA |
α-lipoic acid |
LC3B |
microtubule-associated protein |
LDHA |
lactate dehydrogenase A |
MAPK |
mitogen-activated protein kinase |
MCT |
monocarboxylate transporter |
MDR |
multidrug resistant protein |
MGMT |
O6-methylguanine-DNA methyltransferase |
MOM |
mitochondrial outer membrane |
MPC |
mitochondrial pyruvate carrier |
MSI |
microsatellite instable |
MSS |
microsatellite stable |
mtDNA |
mitochondrial DNA |
MTD |
maximum tolerable dose |
MTHFD2 |
methylenetetrahydrofolate dehydrogenase |
mTOR |
mammalian target of rapamycin |
MYC |
myelocytomatosis |
NFκB |
nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells |
Nrf |
nuclear factor erythroid-2-related factor |
OXPHOS |
oxidative phosphorylation |
PARP |
poly(ADP-ribose) polymerase |
PDGF |
platelet-derived growth factor |
PGC |
peroxisome proliferator-activated receptor gamma coactivator |
PDC |
pyruvate dehydrogenase complex |
PDCD4 |
programmed cell death protein |
PDK |
pyruvate dehydrogenase kinase |
PEG2 |
prostaglandin E2 |
PEG |
polyethylene glycol |
PET |
positron emission tomography |
PFK |
phosphofructokinase |
PHD |
prolyl hydroxylase domain protein |
PI3K |
phosphoinositide 3-kinases |
PIP2 |
phosphatidylinositol-4,5-bisphosphate |
PIP3 |
phosphatidyl-inositol-3,4,5-trisphosphate |
PKM |
pyruvate kinase |
PPP |
pentose phosphate pathway |
ROS |
reactive oxygen species |
RTK |
receptor tyrosine kinases |
S6K1 |
p70S6 Kinase 1 |
S9 |
supernatant 9000 g,— |
SCO |
synthesis of cytochrome c oxidase |
SLC |
solute carrier |
SREBP |
sterol responsive element binding protein |
TAM |
tumor associated macrophages |
TCA |
tricarboxylic acid cycle |
Teff cell |
effector T cell |
TGF |
transforming growth factor |
TME |
tumor microenvironment |
TIGAR |
TP53-inducible glycolysis and apoptosis regulator |
Treg cell |
regulatory T cell |
VEGF |
vascular endothelial growth factor |